TITLE

HUMAN SUBJECTS

AUTHOR(S)
Dello Russo, Nicholas M.
PUB. DATE
January 2008
SOURCE
Journal of the American Dental Association (JADA);Jan2008, Vol. 139 Issue 1, p16
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article "Ethical Considerations in Publishing Research Involving Human Subjects," by Michael Glick, in the October 2007 issue.
ACCESSION #
28655236

 

Related Articles

  • TGN1412—a regulator's perspective. Schneider, Christian K.; Kalinke, Ulrich; Löwer, Johannes // Nature Biotechnology;May2006, Vol. 24 Issue 5, p493 

    A letter to the editor is presented in response to an editorial about the risks inherently associated with first-in-human studies of TGN1412, a new monoclonal antibodies.

  • Broadening GCP. Getz, Kenneth // Applied Clinical Trials;Jun2004, Vol. 13 Issue 6, p14 

    Presents a letter to the editor about good recruitment practice of patients for clinical trials.

  • Disparities in Participation in Cancer Clinical Trials—Reply. Murthy, Vivek H.; Krumholz, Harlan M.; Gross, Cary P. // JAMA: Journal of the American Medical Association;8/25/2004, Vol. 292 Issue 8, p922 

    Presents a reply by Vivek Murthy and colleagues to a letter to the editor about their article "Participation in cancer clinical trials: race-, sex-, and age-based disparities."

  • Disparities in Participation in Cancer Clinical Trials. Bjarnason, Nina H. // JAMA: Journal of the American Medical Association;8/25/2004, Vol. 292 Issue 8, p922 

    Presents a letter to the editor in response to the article "Participation in cancer clinical trials: race-, sex-, and age-based disparities," by Vivek Murthy and colleagues.

  • Human Testing: Sass and Needleman Respond to Industry. Sass, Jennifer B.; Needleman, Herbert L. // Environmental Health Perspectives;May2004, Vol. 112 Issue 6, pA 340 

    Presents a letter to the editor commenting on an article published in the periodical "Environmental Health Perspectives" concerning the issue of human experimentation.

  • Testing Toxic Compounds in Human Subjects: Ethical Standards and Good Science. Links, Jonathan M.; Goldman, Lynn R. // Environmental Health Perspectives;Jun2004, Vol. 112 Issue 8, pA458 

    Presents a letter to the editor on testing toxic compounds in human subjects.

  • Medicine for the boss. Zammit, Frances // New Scientist;8/19/2006, Vol. 191 Issue 2565, p21 

    A letter to the editor is presented in response to an article related to human experimentation in medicine in the July 29, 2006 issue.

  • Phase 0 (Zero) clinical trials: A myth or reality? Jain, A. // Indian Journal of Cancer;Jan-Mar2010, Vol. 47 Issue 1, p70 

    A letter to the editor is presented regarding phase 0 trials which are considered the first human trials without therapeutic or diagnostic intent.

  • Factual error. Bilodeau, Michel; Leonard, Michael // CMAJ: Canadian Medical Association Journal;3/31/2009, Vol. 180 Issue 7, p738 

    A letter to the editor is presented in response to the article "Clinical trials: chasing recruits," by Ann Silversides in the 2009 issue.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics